RBC Capital Markets and RBC Foundation USA’s 8-year Legacy of Support for EB Research Partnership Surpasses $230,000 for Rare Disease ResearcH

EBRP announced a $35,000 gift from longtime supporter, RBC Foundation USA, extending our 8-year partnership, which has surpassed $230,000 in funding for life-saving EB research projects and therapies. Since RBC Capital Markets and RBC Foundation USA’s inaugural gifts in 2013, EBRP has funded 75 projects under their innovative Venture Philanthropy model, directly impacting the clinical landscape; the number of clinical trials in EB has increased by 15x, from 2 when they started to more than 30 today, including 4 Phase III clinical trials for the first time ever.

read more